de Melo Campos, P., Machado-Neto, J. A., Lorand-Metze, I., Costa, F. F., Olalla Saad, S. T., & Traina, F. (2018). IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes. Hematol Transfus Cell Ther.
Chicago Style Citationde Melo Campos, Paula, João Agostinho Machado-Neto, Irene Lorand-Metze, Fernando Ferreira Costa, Sara Teresinha Olalla Saad, i Fabiola Traina. "IRAK1 Expression in Bone Marrow Cells Does Not Impact Patient Outcomes in Myelodysplastic Syndromes." Hematol Transfus Cell Ther 2018.
Cita MLAde Melo Campos, Paula, et al. "IRAK1 Expression in Bone Marrow Cells Does Not Impact Patient Outcomes in Myelodysplastic Syndromes." Hematol Transfus Cell Ther 2018.
Atenció: Aquestes cites poden no estar 100% correctes.